{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:24:20Z","timestamp":1772889860450,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","award":["NIH R01 AI 111820"],"award-info":[{"award-number":["NIH R01 AI 111820"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","award":["2I01BX000624"],"award-info":[{"award-number":["2I01BX000624"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","award":["NIH U19 AI 095227-02"],"award-info":[{"award-number":["NIH U19 AI 095227-02"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","award":["NIH R01 HL 090664-04"],"award-info":[{"award-number":["NIH R01 HL 090664-04"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.prostaglandins.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T17:10:44Z","timestamp":1523639444000},"page":"33-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-9118","authenticated-orcid":false,"given":"Shinji","family":"Toki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weisong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasia","family":"Goleniewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Dulek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn C.","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-7875","authenticated-orcid":false,"suffix":"Jr","given":"R. Stokes","family":"Peebles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0005","series-title":"Breathing in America: Diseases, Progress and Hope","first-page":"15","article-title":"Acute respiratory distress syndrome","author":"Hudson","year":"2010"},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.04.001_bib0010","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.prostaglandins.2018.04.001_bib0015","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.04.001_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment","volume":"6","author":"Matthay","year":"2011","journal-title":"Ann. Rev. Pathol.: Mech. Dis."},{"issue":"16","key":"10.1016\/j.prostaglandins.2018.04.001_bib0025","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa050333","article-title":"Incidence and outcomes of acute lung injury","volume":"353","author":"Rubenfeld","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.04.001_bib0030","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1378\/chest.07-2134","article-title":"Mortality rates for patients with acute lung injury\/ARDS have decreased over time","volume":"133","author":"Zambon","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0035","first-page":"CD002787","article-title":"Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults, Cochrane Database Syst","volume":"6","author":"Gebistorf","year":"2016","journal-title":"Rev"},{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0040","doi-asserted-by":"crossref","first-page":"17654","DOI":"10.1038\/srep17654","article-title":"The effectiveness of corticosteroids on mortality in patients with acute respiratory distress syndrome or acute lung injury: a secondary analysis","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.04.001_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-0033-1351119","article-title":"Treatment of acute lung injury: current and emerging pharmacological therapies","volume":"34","author":"Sweeney","year":"2013","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"Supplement","key":"10.1016\/j.prostaglandins.2018.04.001_bib0050","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1097\/01.CCM.0000057843.47705.E8","article-title":"Neutrophils and acute lung injury","volume":"31","author":"Abraham","year":"2003","journal-title":"Crit. Care Med."},{"issue":"3\u20134","key":"10.1016\/j.prostaglandins.2018.04.001_bib0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2119\/molmed.2010.00138","article-title":"Contribution of neutrophils to acute lung injury","volume":"17","author":"Grommes","year":"2011","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.04.001_bib0060","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/cc5090","article-title":"Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome","volume":"10","author":"Fialkow","year":"2006","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.04.001_bib0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1164\/ajrccm.150.1.8025736","article-title":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome","volume":"150","author":"Steinberg","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S36436","article-title":"Clinical evaluation of sivelestat for acute lung injury\/acute respiratory distress syndrome following surgery for abdominal sepsis","volume":"6","author":"Tsuboko","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.04.001_bib0075","doi-asserted-by":"crossref","first-page":"L1137","DOI":"10.1152\/ajplung.2000.279.6.L1137","article-title":"Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury","volume":"279","author":"Abraham","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.04.001_bib0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2013.10.008","article-title":"Lipid mediators in immune dysfunction after severe inflammation","volume":"35","author":"Fullerton","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-394300-2.00005-3","article-title":"Prostanoids as regulators of innate and adaptive immunity","volume":"116","author":"Hirata","year":"2012","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.04.001_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJM199007053230106","article-title":"Regulatory functions of the vascular endothelium","volume":"323","author":"Vane","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.04.001_bib0095","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00011-011-0317-6","article-title":"Prostaglandin I2 analogues suppress TNF-\u03b1 expression in human monocytes via mitogen-activated protein kinase pathway","volume":"60","author":"Wang","year":"2011","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.04.001_bib0100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1155\/S0962935196000026","article-title":"Modulation of macrophage activation by prostaglandins","volume":"5","author":"Sautebin","year":"1996","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.04.001_bib0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.178.2.702","article-title":"Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells","volume":"178","author":"Zhou","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2018.04.001_bib0110","doi-asserted-by":"crossref","first-page":"L615","DOI":"10.1152\/ajplung.00224.2010","article-title":"PGI synthase overexpression protects against bleomycin-induced mortality and is associated with increased nqo 1 expression","volume":"301","author":"Zhou","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.04.001_bib0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.23.021704.115653","article-title":"How neutrophils kill microbes","volume":"23","author":"Segal","year":"2005","journal-title":"Annu. Rev. of Immunol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.04.001_bib0120","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.RES.60.5.666","article-title":"Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart","volume":"60","author":"Simpson","year":"1987","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.04.001_bib0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1183\/09031936.00148311","article-title":"Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury","volume":"41","author":"Birukova","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.prostaglandins.2018.04.001_bib0130","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.yexcr.2007.03.036","article-title":"Prostaglandins PGE2 and PGI2 promote endothelial barrier enhancement via PKA- and epac1\/rap1-dependent rac activation","volume":"313","author":"Birukova","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.04.001_bib0135","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbadis.2014.12.016","article-title":"Prostacyclin post-treatment improves LPS-induced acute lung injury and endothelial barrier recovery via rap1","volume":"1852","author":"Birukova","year":"2015","journal-title":"Biochim. Biophys. Acta."},{"issue":"5567","key":"10.1016\/j.prostaglandins.2018.04.001_bib0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1068711","article-title":"Role of prostacyclin in the cardiovascular response to thromboxane A2","volume":"296","author":"Cheng","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.prostaglandins.2018.04.001_bib0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J. Immunol. Methods"},{"issue":"11","key":"10.1016\/j.prostaglandins.2018.04.001_bib0150","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.4049\/jimmunol.1103426","article-title":"Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models","volume":"188","author":"Lacey","year":"2012","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.prostaglandins.2018.04.001_bib0155","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.200903-0322OC","article-title":"Contribution of epithelial-derived fibroblasts to bleomycin-induced fibrosis","volume":"180","author":"Tanjore","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0160","first-page":"203","article-title":"Lipid mediators of hypersensitivity and inflammation, In: middleton's allergy, principles and practice","author":"Peebles","year":"2008","journal-title":"Elsevier Health Sci."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.04.001_bib0165","doi-asserted-by":"crossref","first-page":"L1083","DOI":"10.1152\/ajplung.2000.279.6.L1083","article-title":"Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide","volume":"279","author":"Chignard","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0170","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/619523","article-title":"Contribution of lung macrophages to the inflammatory responses induced by exposure to air pollutants","author":"Hiraiwa","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.04.001_bib0175","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI117392","article-title":"Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products","volume":"94","author":"Crestani","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.04.001_bib0180","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/HYPERTENSIONAHA.108.112029","article-title":"Activation of the PGI2\/IP system contributes to the development of circulatory failure in a rat model of endotoxic shock","volume":"52","author":"H\u00f6cherl","year":"2008","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.prostaglandins.2018.04.001_bib0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0190","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1602090","article-title":"15-epi-Lipoxin A4 resolvin D2, and resolvin D3 induceNF-kB regulators in bacterial pneumonia","volume":"200","author":"Sham","year":"2018","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.04.001_bib0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.04.001_bib0200","doi-asserted-by":"crossref","first-page":"L342","DOI":"10.1152\/ajplung.00016.2004","article-title":"Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide","volume":"288","author":"Kida","year":"2005","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"8","key":"10.1016\/j.prostaglandins.2018.04.001_bib0205","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span","volume":"214","author":"Misharin","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prostaglandins.2018.04.001_bib0210","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/926968","article-title":"PGI2 as a regulator of inflammatory diseases","author":"Dorris","year":"2012","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.04.001_bib0215","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4187\/respcare.01752","article-title":"Successful epoprostenol withdrawal in pulmonary arterial hypertension: case report and literature review","volume":"58","author":"Demerouti","year":"2013","journal-title":"Respir. Care"},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.04.001_bib0220","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.04.001_bib0225","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.rmed.2010.12.018","article-title":"Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs","volume":"105","author":"Safdar","year":"2011","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.04.001_bib0230","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/VHRM.S3998","article-title":"Arterial pulmonary hypertension in noncardiac intensive care unit","volume":"4","author":"Tsapenko","year":"2008","journal-title":"Vasc. Health Risk Manage."},{"issue":"2","key":"10.1016\/j.prostaglandins.2018.04.001_bib0235","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1440-1843.2004.00568.x","article-title":"Polymorphism of the promoter region of prostacyclin synthase gene in chronic thromboembolic pulmonary hypertension","volume":"9","author":"Amano","year":"2004","journal-title":"Respirology"},{"issue":"11","key":"10.1016\/j.prostaglandins.2018.04.001_bib0240","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/jmv.21318","article-title":"Functional polymorphism of the promoter region of the prostacyclin synthase gene and severity of RSV infection in hospitalized children","volume":"80","author":"Hashimoto","year":"2008","journal-title":"J. Med. Virol."},{"issue":"18","key":"10.1016\/j.prostaglandins.2018.04.001_bib0245","doi-asserted-by":"crossref","first-page":"15439","DOI":"10.1074\/jbc.M201187200","article-title":"Impaired receptor binding and activation associated with a human prostacyclin receptor polymorphism","volume":"277","author":"Stitham","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.prostaglandins.2018.04.001_bib0250","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jocn.2012.06.011","article-title":"Effect of single nucleotide polymorphisms of the prostacyclin receptor gene on platelet activation in Japanese healthy subjects and patients with cerebral infarction","volume":"20","author":"Shimizu","year":"2013","journal-title":"J. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.prostaglandins.2018.04.001_bib0255","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7098","article-title":"A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury","volume":"12","author":"Flores","year":"2008","journal-title":"Crit. Care"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317301168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317301168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T03:24:15Z","timestamp":1693625055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317301168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":51,"alternative-id":["S1098882317301168"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.04.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}